Copyright © 2009  by "International Journal of Pharmaceutica Research and Development"  ·  All Rights reserved  ·  E-Mail: info@ijprd.com
Welcome to "International Journal of Pharmaceutical Research and Development"  i.e. "IJPRD"
HOW TO PREPARE   
YOUR PAPER
What's New | Feedback | Copyright and Disclaimer
Past Issues

March 2009

April 2009

May 2009

June 2009

July 2009

August 2009

September 2009

October 2009

November 2009

December 2009

January 2010

February 2010

March 2010

April 2010

May 2010

June 2010


July 2010
Online Since : March 2009
Only 15 Articles will be Published in Each Issues
TODAY IS
Abstract Content
Model Abstract
Summary Content
Model Summary

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT
- : BACK TO CURRENT ISSUE OF JOURNAL :-
((( PREVIOUS ARTICLE
[ VIEW FULL ARTICLE ] [PDF VIEW ]
August - 2010 / Volume - 2/Issue - 6
( Total Articles =15 )
August 2010 Issue
NEXT ARTICLE )))
ABSTRACT

    Oseltamivir phosphate (OP) is an antiviral drug that is used in the treatment and prophylaxis of both influenza A and influenza B. It is effective against all known influenza viruses than can infect humans, including pandemic influenza viruses and may be the most appropriate antiviral option against avian influenza caused by H5N1 virus. Tamiflu®, the registered trademark used under exclusive license by Roche laboratories with OP as active pharmaceutical ingredient, is considered the best treatment for the bird flu disease.
The construction and electrochemical response characteristics of poly vinyl chloride (PVC) membrane sensors for the determination of (OP) were described. The sensors are based on the use of the ion association complexes of (OP) cation with sodium tetraphenylborate - oseltamivir Phosphate  (NaTPB-OP), tungestosilisate - oseltamivir phosphate (TS-OP), phosphomolbdate - oseltamivir phosphate (PM-OP) and phosphotungestate - oseltamivir phosphate (PT-OP)   as ion exchange sites in the PVC matrix. The performance characteristics of these sensors, which were evaluated according to IUPAC recommendations, reveal a fast, stable and linear response for (OP) over the concentration range 10-5 to 10-2 mol L-1with cationic slopes of 51.5±0.3, 50±0.5, 55±0.2 and 50±0.4 mV per decade across an extended OP concentration range from 1.0×10-6 to 1.0×10-2 mol L-1 for NaTPB-OP, TS-OP, PM-OP and PT-OP, respectively. The direct potentiometric determination of (OP) using the proposed sensors gave average recoveries of 99.9, 99.8, 99.9 and 99.7 for NaTPB-OP, TS-OP, PM-OP and PT-OP respectively. The sensors are used for determination of (OP) in tablets. The method was successfully applied to commercial pharmaceuticals, Tamiflu®. Validation of the method shows suitability of the proposed sensors for use in the quality control assessment of (OP). The developed method was found to be simple, accurate and precise when compared with a reported HPLC method.


Key words:
Oseltamivir phosphate (Tamiflu); Ion selective electrodes; PVC membranes; sodium tetraphenylborate; tungestosilisate; phosphomolbdate; phosphotungestate.
Article No 2
August - 2010 / Volume - 2 / Issue - 6/ Article No - 2 / Research Article

A NOVEL POTENTIOMETRIC METHOD FOR DETERMINATION OF OSELTAMIVIR PHOSPHATE (TAMIFLU) AND ITS PHARMACEUTICAL APPLICATIONS


  Salem M. Hamza1,Nashwa MH. Rizk2,
Hamdy AB. Matter1


1Chemistry Department Faculty of science,
Menoufia University. Egypt,
2Genetic Engineering and Biotechnology
Research Institute, Menoufia University. Egypt,
Email: ahmed_matter111@yahoo.com

Salem M. Hamza